Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Advanced Cancer × Palliative Care × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 4 Breast Neoplasms 3 Ovarian Neoplasms 2 Lung Neoplasms 2 Fatigue 2 Uterine Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Rectal Neoplasms 1 Pancreatic Neoplasms 1 Oropharyngeal Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Lymphoma 1 Genital Neoplasms, Female 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Disease Progression 1 Colonic Neoplasms 1 Cognitive Dysfunction 1 Carcinoma, Renal Cell 1 Carcinoma, Non-Small-Cell Lung 1 Bone Neoplasms 1 Adolescent and Young Adult Cancer Patient 1

Interventions

Nivolumab 7 linrodostat 3 Ipilimumab 3 relatlimab 2 Pemetrexed 2 tislelizumab 1 regorafenib 1 ralimetinib 1 p38 Mitogen-Activated Protein Kinases 1 figitumumab 1 efatutazone 1 abemaciclib 1 Vorinostat 1 Tamoxifen 1 Sunitinib 1 Ranitidine 1 Midazolam 1 LY2603618 1 LY2584702 1 Gemcitabine 1 Fulvestrant 1 Dasatinib 1 Crizotinib 1 Cetuximab 1 Carboplatin 1 BMS-813160 1 3-(9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-imidazo(1,2-a)pyridin-3-yl-1H-pyrrole-2,5-dione 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡